Iris Manthey Selected Research

sibutramine (Meridia)

2/2008

A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iris Manthey Research Topics

Disease

1	Heart Failure 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013
1	Insulin Resistance 08/2010
1	Cardiomyopathies (Cardiomyopathy) 06/2009
1	Weight Loss (Weight Reduction) 02/2008
1	Body Weight (Weight, Body) 02/2008
1	Obesity 04/2002
1	Hypertension (High Blood Pressure) 04/2002

Drug/Important Bio-Agent (IBA)

2	GTP-Binding Proteins (G-Protein)IBA 06/2009 - 02/2008
2	Adrenergic Receptors (Adrenergic Receptor)IBA 06/2009 - 02/2008
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Insulin (Novolin)FDA Link 08/2010
1	Transcription Factors (Transcription Factor)IBA 02/2008
1	sibutramine (Meridia)FDA Link 02/2008
1	Proteins (Proteins, Gene)FDA Link 02/2008
1	G-protein beta3 subunitIBA 04/2002
1	DiureticsIBA 04/2002

Therapy/Procedure

1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2013
1	Caloric Restriction 02/2008
1	Therapeutics 04/2002